Shares of regenerative medicine stem cell companies have mediocre volume but stealth upward movement during negative market gyrations Read more…
Shares of regenerative medicine stem cell companies have been subject to continuous market gyrations. Read more…
Shares of regenerative medicine stem cell companies were UP from unheraled LOWS due to macro issues and negative market gyrations. Read more…
Shares of regenerative medicine stem cell companies have been relatively EVEN although down due to macro issues and negative market gyrations. Read more…
Shares of regenerative medicine stem cell companies were resurrected from depreciating markets on Wednesday, 5/25/11. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.